Since Intec Pharma Ltd. (NASDAQ:NTEC) and Sierra Oncology Inc. (NASDAQ:SRRA) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affect the profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation of both companies.
Earnings and Valuation
In table 1 we can see Intec Pharma Ltd. and Sierra Oncology Inc.’s top-line revenue, earnings per share (EPS) and valuation.
Table 2 provides us Intec Pharma Ltd. and Sierra Oncology Inc.’s return on assets, net margins and return on equity.
Institutional and Insider Ownership
The shares of both Intec Pharma Ltd. and Sierra Oncology Inc. are owned by institutional investors at 39.64% and 67.2% respectively. About 11.81% of Intec Pharma Ltd.’s share are held by insiders. Competitively, insiders own roughly 0.1% of Sierra Oncology Inc.’s shares.
In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of